Travere Therapeutics, Inc.
TVTX
60 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | Nov 4 9:14 PM | SANDRA CALVIN | Proposed Sale | 67,115 | $36.00 | $2.4M | — | View → |
| Oct 31, 2025 | Oct 31 8:05 PM | Coughlin Timothy | Proposed Sale | 18,000 | $34.98 | $629.7K | — | View → |
| Oct 31, 2025 | Oct 31 6:51 PM | Heerma Peter | Proposed Sale | 5,591 | $35.00 | $195.7K | — | View → |
| Oct 29, 2025 | Oct 29 8:26 PM | Dube Eric M | Proposed Sale | 27,128 | $30.12 | $817.0K | — | View → |
| Oct 28, 2025 | Oct 28 8:57 PM | Dube Eric M | Proposed Sale | 92,872 | $30.38 | $2.8M | — | View → |
| Oct 28, 2025 | Oct 28 6:08 PM | Heerma Peter | Proposed Sale | 2,662 | $30.00 | $79.9K | — | View → |
| Sep 22, 2025 | Sep 22 8:02 PM | ELIZABETH REED | Proposed Sale | 10,000 | $25.00 | $250.0K | — | View → |
| May 5, 2025 | May 5 11:45 PM | Christopher Cline | Proposed Sale | 1,784 | $21.05 | $37.6K | — | View → |
| May 5, 2025 | May 5 11:41 PM | Peter Heerma | Proposed Sale | 1,771 | $21.05 | $37.3K | — | View → |
| May 5, 2025 | May 5 3:32 PM | REED ELIZABETH E | Proposed Sale | 4,920 | $21.05 | $103.6K | — | View → |
| May 5, 2025 | May 5 3:20 PM | Dube Eric M | Proposed Sale | 18,924 | $21.05 | $398.4K | — | View → |
| May 5, 2025 | May 5 2:08 PM | ROTE WILLIAM E. | Proposed Sale | 3,198 | $21.05 | $67.3K | — | View → |
| Apr 11, 2025 | Apr 11 11:03 PM | Christopher Cline | Proposed Sale | 48 | $13.14 | $631 | — | View → |
| Feb 12, 2025 | Feb 13 12:47 AM | Peter Heerma | Proposed Sale | 2,568 | $23.53 | $60.4K | — | View → |
| Feb 12, 2025 | Feb 13 12:46 AM | Jula Inrig | Proposed Sale | 2,568 | $23.53 | $60.4K | — | View → |
| Feb 12, 2025 | Feb 12 4:03 PM | ROTE WILLIAM E. | Proposed Sale | 5,200 | $23.53 | $122.4K | — | View → |
| Feb 12, 2025 | Feb 12 2:52 PM | REED ELIZABETH E | Proposed Sale | 8,000 | $23.53 | $188.2K | — | View → |
| Feb 11, 2025 | Feb 11 9:08 PM | SANDRA CALVIN | Proposed Sale | 54,244 | $25.00 | $1.4M | — | View → |
| Feb 11, 2025 | Feb 11 9:04 PM | PETER HEERMA | Proposed Sale | 3,074 | $25.00 | $76.8K | — | View → |
| Feb 11, 2025 | Feb 11 4:56 PM | Dube Eric M | Proposed Sale | 11,375 | $24.04 | $273.5K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | May 4 8:27 PM | Roy D. BaynesDirector | Option Exercise | 9,750 | $6.82 | 9,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | LYONS GARY ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Roy D. BaynesDirector | Option Exercise | 32,750 | $21.38 | 6,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 15,250 | $22.40 | 19,500(D) | View → |
| Apr 14, 2026 | Apr 16 1:47 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 37,500 | $19.08 | 20,000(D) | View → |
| Apr 6, 2026 | Apr 7 10:17 PM | Roy D. BaynesDirector | Option Exercise | 10,000 | $26.52 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $15.46 | 45,000(D) | View → |
| Mar 16, 2026 | Mar 18 8:05 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 10,000(D) | View → |
| Feb 20, 2026 | Feb 24 9:05 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 60,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:10 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 20,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 303,600 | $33.10 | 303,600(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 69,640 | $33.10 | 69,640(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | William E. RoteChief Research Officer | Grant/Award | 53,570 | $33.10 | 53,570(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Grant/Award | 20,160 | $33.10 | 20,160(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Elizabeth E ReedChief Legal Officer and GC | Grant/Award | 66,960 | $33.10 | 66,960(D) | View → |
| Jan 27, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 51,865 | $15.46 | 120,000(D) | View → |
| Jan 23, 2026 | Jan 28 1:25 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 8,135 | $15.46 | 171,865(D) | View → |